Skip to main content
. Author manuscript; available in PMC: 2024 Dec 18.
Published in final edited form as: Nat Rev Bioeng. 2024 Sep 23;2(11):916–929. doi: 10.1038/s44222-024-00231-z

Fig. 3 |. Research and investment in oncolytic viruses.

Fig. 3 |

a, Peer-reviewed publications in 1990–2024 involving different types of oncolytic virus. Search terms in PubMed: [oncolytic virus] AND [cancer] AND [virus type name]. b, Clinical trials using oncolytic viruses in 1990–2024. Oncolytic viruses undergoing clinical trials were extracted from the Clinicaltrials.gov database using the following keywords in titles and abstracts: oncolytic virus, adenovirus, poxvirus, vaccinia, coxsackievirus, herpes simplex virus (HSV), measles virus, Newcastle disease virus, parvovirus, reovirus, Seneca Valley virus, vesicular stomatitis virus (VSV), poliovirus and cancer. c, Patents filed for oncolytic-virus platforms from 2010 to 2024 in the USA. Search terms in Google patents include [oncolytic virus] AND [cancer] + [country = USA].